Guilford Genomic Medicine Initiative (GGMI) | NCT01372553 | Trialant
CompletedObservationalUpdated Apr 16, 2014
Guilford Genomic Medicine Initiative (GGMI)
Guilford Genomic Medicine Initiative (GGMI)
ClinicalTrials.gov ID
NCT01372553
Lead Sponsor
The Moses H. Cone Memorial HospitalOTHER
Overall Status
Completed
Study Type
Observational
Enrollment
1,184Actual
Last Update Posted
Apr 16, 2014Estimated
Start Date
Oct 2009
Primary Completion Date
Apr 2012Actual
Completion Date
Apr 2012Actual
Official Title
Guilford Genomic Medicine Initiative (GGMI)
Brief Summary
Genomic medicine, using genetic information to improve health outcomes, is heralded as the answer to rising medical costs by focusing on prevention and tailored care. Despite its potential, little investigation has focused on how genomic medicine can be applied in health care. To be effective, it requires new ways to learn, deliver, and communicate medical information. It will also raise new ethical questions.
The overall goal of Guilford Genomic Medicine Initiative (GGMI) is to identify the specific challenges in "re-structuring" an existing medical system to integrate genomic medicine, and create solutions that can be used by other medical systems, such as the extensive military medical care system. To accomplish this goal, GGMI includes the development of a large-scale genomic medicine education initiative targeted at the community, providers, and patients, and a clinical systems model to implement strategies to facilitate the integration of genomic medicine into several pilot practices.
Breast Cancer
Ovarian Cancer
Colon Cancer
Thrombophilia
No interventions
There are no interventions for this study.
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
All patients scheduled for an upcoming well or new visit within the next 3 weeks with their primary care physician (at the two implementation clinics).